|
![]() For a description of drugs listed on this page go to Medline Plus. For some drugs and in other instances noted below you will need to complete a Medication Exception Form Anti-HIV Drugs
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Protease Inhibitors
Entry Inhibitors
Medical Criteria Medication specific criteria for NRTIs, NNRTIs, PIs, and Multi-Class Agents except where otherwise indicated:
Aptivus (tipranavir) NRTI and NNRTI experienced; CD4 less than 300 or 20%; viral load greater than 400 AND resistance, intolerance or treatment failure to 2 or more PIs. ADAP Medication Exception Form documenting authorized indications in the “Reason for Exception” section is required, with updated prescription and CD4/viral load every 3 months. Medication Exception Form required Norvir (ritonavir, RTV) Abbott Laboratories, manufacturer of Norvir, is currently making this medication available to clients who are on 400 mg per day or higher without charge to client or ADAP through their Patient Assistance Program. Clients or medical providers can contact the program directly at 1-800-222-6885. The website address is www.abbott.com. For more information, contact VDH ADAP Coordinator at (804) 864-8019. Prezista (darunavir, TMC114) NRTI and NNRTI experienced; CD4 less than 300 or 20%; viral load greater than 400 AND Resistance, intolerance or treatment failure to 2 or more PIs. ADAP Medication Exception Form documenting authorized indications in the "Reason for Exception" section is required, with updated prescription and CD4/viral load every 3 months. Medication Exception Form required Fuzeon (enfuvirtide, T-20) NRTI and NNRTI experienced; CD4 less than 300 or 20%; viral load greater than 400 AND resistance, intolerance or treatment failure to 2 or more PIs. ADAP Medication Exception Form documenting authorized indications in the “Reason for Exception” section is required, with updated prescription and CD4/viral load every 3 months. Medication Exception Form Required. Health care providers who have clinical questions may contact their Regional AIDS Resource and Consultation Centers:
Eastern: 800-999-8385 / 757-446-6170 Northern: 800-828-4927 Northwest: 800-421-1102 Southwest: 800-950-4056 | We can help explain any program (such as ADAP, Medicaid, Insurance Plans, Medicare, Medicare Part D, etc.) and assist you to decide what program or programs are options. You can either use the contact information and links on these pages yourself, or we will assist you at any stage in the process. If you don't know where to start, let us know by e-mail, phone or fax and we'll create a strategy with you and any health care or support provider you may already have.
About Virginia - Eligibility for ADAP and other programs is determined at local health departments or through Virginia Commonwealth University Health Systems Financial Counseling and Governmental Services. If you have any questions The Virginia HIV/STD/Viral Hepatitis Hotline provides statewide toll-free lines to answer questions and provide crisis intervention, referrals and written educational materials regarding Sexually Transmitted Diseases (STDs), HIV and AIDS. The number is (800) 533-4148. You can also e-mail the hotline at hiv-stdhotline@vdh.virginia.gov. Vaccines
Hepatitis C Treatment - Monthly Prescriptions needed
Opportunistic Infection Protection/Treatment
Adjuvant Therapy
Patient Assistance Programs - Free or reduced price medications are offered by individual drug companies, as well as other organizations and foundations. All prescription drugs, including generic drugs, are made by drug companies. Information includes: Who you should call or e-mail about getting treatments,and financial and medical eligibility criteria. Although they will not automatically cover "the doughnut hole" or co-pays if you have Medicare Part D, some program are willing to make arrangements and even check out any benefits for which you are eligible. If you need help, contact them directly or let us know what drug you are interested in, or if you are trying to contact a specific company, foundation or organization and contact The Network at network@atdn.org |
| Treatment News • Home • Hepatitis
• About
The Network • The
Access Project • Simple Fact Sheets
Last
modified: 3/24/07 |